Indications Under Development
Innovation With Speed
Reistone Biopharma is focused on the research and development of innovative medicines through global collaborations with sense of urgency.
Patient Need Is Our Passion
Research & Development
At Reistone, we devise our clinical research and development strategy around three key pillars: science, patient and market. These key pillars serve as our guiding principles in medicine development.
Reistone Biopharma's oral Ivarmacitinib Meets Primary Endpoint in Phase III Study for Atopic Dermatitis
Reistone Announces Positive Topline Phase 2 Results for SHR0302, a Selective JAK1 Inhibitor, for Treatment of Patients with Alopecia Areata
Partnership is core to our business model. We are committed to partnering with R&D based global pharma and biotech companies to bring innovative medicines to patients.
People represent our key success pillar. We are keen to recruit new talent into Reistone where you can develop and achieve your career aspirations.
Room 203, 2F, Xiangke Road,
Zhangjiang Hi-Tech Park,
Room 110, 3F, Air China Century Building,
No.40 Xiaoyun Road,
Chaoyang District,Beijing, China,100027
1 Lincoln Street,